Trademark: 79208840
Word
SDCORD
Status Date
Friday, May 31, 2024
Registration Number
5332245
Registration Date
Tuesday, November 14, 2017
Filing Date
Thursday, March 30, 2017
Published for Opposition
Tuesday, August 29, 2017
Cancellation Date
Friday, May 31, 2024
5 Cell products for treating cancer, namely, cells for medical use in the field of immuno-oncology
Jun 1, 2017
Sn Assigned For Sect 66a Appl From Ib
Jul 14, 2017
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jul 17, 2017
Teas Response To Office Action Received
Jun 5, 2017
New Application Office Supplied Data Entered
Jun 9, 2017
Application Filing Receipt Mailed
Jun 21, 2017
Assigned To Examiner
Jun 23, 2017
Non-Final Action Written
Jun 24, 2017
Non-Final Action (Ib Refusal) Prepared For Review
Jul 1, 2017
Refusal Processed By Mpu
Jul 1, 2017
Non-Final Action Mailed - Refusal Sent To Ib
Jul 14, 2017
Attorney/Dom.Rep.Revoked And/Or Appointed
Aug 9, 2017
Notification Of Notice Of Publication E-Mailed
Aug 29, 2017
Published For Opposition
Aug 29, 2017
Official Gazette Publication Confirmation E-Mailed
Nov 14, 2017
Registered-Principal Register
Feb 14, 2018
Final Disposition Notice Created, To Be Sent To Ib
Feb 20, 2018
Final Disposition Processed
Jul 17, 2017
Correspondence Received In Law Office
Jul 17, 2017
Teas/Email Correspondence Entered
Jul 17, 2017
Approved For Pub - Principal Register
Jul 21, 2017
Refusal Processed By Ib
Apr 13, 2018
Final Decision Transaction Processed By Ib
Nov 14, 2022
Courtesy Reminder - Sec. 71 (6-Yr) E-Mailed
May 31, 2024
Cancelled Section 71
Dec 8, 2023
New Representative At Ib Received
Feb 20, 2018
Final Disposition Notice Sent To Ib
May 24, 2018
Change Of Name/Address Rec'd From Ib
Trademark Alertz updated from USPTO on 2030-01-24
